amfAR, The Foundation for AIDS Research
amfAR plays a vital role in AIDS research, identifying critical gaps in our knowledge of HIV and AIDS, and supporting groundbreaking studies that often lack the preliminary data required by more traditional funders.
amfAR has awarded $1 million in phase II funding for projects applying cutting-edge technologies to HIV cure research.
An intriguing new finding has the scientific community abuzz
An new round of innovative cure-focused research grants pairs leading bioengineers with established HIV scientists.
Headquartered at the University of California, San Francisco, the amfAR Institute represents an exciting new collaboration in the search for a cure for HIV.
Our goal is to develop the scientific basis for a cure by the end of 2020.
The amfAR Research Consortium on HIV Eradication, or ARCHE, is enabling teams of researchers to collaborate.
The first FDA-approved gene therapy treatment for cancer patients has shown promise in suppressing HIV infection long term in lab monkeys, according to a study partially funded by amfAR.
amfAR is focusing on four key questions that need to be answered in order to achieve a cure.
© 2018 amfAR All Rights Reserved